Bravecto Plus Spot On Solution for Cats
Bravecto Plus is a spot on topical medication for the prevention and treatment of flea, ticks, ear mites and intestinal worms. It contains the active ingredients fluralaner and moxidectin.
For application to the back of the neck every 3 months.
Sold as single pipettes available in 3 sizes:
for small cats 1.2 – 2.8 kg
for medium-sized cats >2.8 – 6.25 kg
for large cats >6.25 – 12.5 kg
This is a prescription only medication to be used as directed by your veterinary surgeon.
For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites,
gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated
when use against ticks or fleas and one or more of the other target parasites is indicated at the same
For the treatment of tick and flea infestations in cats providing immediate and persistent flea
(Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must
attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For the treatment of infestations with ear mites (Otodectes cynotis).
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults
of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma
When administered repeatedly at a 12-week interval, the product continuously prevents heartworm
disease caused by Dirofilaria immitis.
Available in 3 sizes:
Small Cat 1.2-2.8kg (112.5mg Fluralaner, 5.6mg Moxidectin)
Medium Cat >2.8-6.25kg (250mg Fluralaner, 12.5mg Moxidectin)
Large Cat >6.25-12.5kg (500mg Fluralaner, 25mg Moxidectin)
Ticks and fleas need to start feeding on the host to become exposed to fluralaner; therefore the risk of
the transmission of parasite borne diseases cannot be excluded.
Cats in areas endemic for heartworm (or those which have travelled to endemic areas) may be infected
with adult heartworms. No therapeutic effect against adult Dirofilaria immitis has been established. It
is therefore recommended, in accordance with good veterinary practice, that animals of 6 months of
age or older and living in areas where a vector exists, should be tested for existing adult heartworm
infections before application of the veterinary medicinal product for the prevention of heartworm
For the prevention of heartworm disease in cats that are only temporarily in endemic areas, the
product should be applied before the first expected exposure to mosquitoes and should be continued at
12-week intervals until return to a non-endemic area. The period between treatment and return from
the endemic areas should not exceed 60 days.
For the treatment of infections with ear mites the need for, and the frequency of, re-treatment as well as the choice of the treatment should be evaluated by the prescribing veterinarian.
Link to the product overview SPC’s for Bravecto Plus Spot On for cats;
Small cats (1.2-2.8kg):
Medium cats (>2.8-6.25kg):
Large cats (6.25-12.5kg):
1 spot on pipette in each pack